by Corporate Image | Sep 16, 2019 | Branstetter Stranch & Jennings
National agreement would settle complaints brought against Purdue by cities/counties, but leaves other defendants to be pursued in court KINGSPORT, Tenn. — A proposed multi-billion dollar settlement and bankruptcy filing by Purdue Pharma in the national opioid...
by Corporate Image | Sep 11, 2019 | Branstetter Stranch & Jennings
Lawsuit against prescription opioid producers to move forward again KNOXVILLE, Tenn. — A landmark regional opioid suit brought by six Tennessee district attorney generals against major pharmaceutical manufacturers is back on track. Judge D. Michael Swiney, Tennessee...
by Corporate Image | Sep 11, 2019 | Branstetter Stranch & Jennings
NASHVILLE, TENN. — Nashville-based Branstetter, Stranch & Jennings (BS&J), PLLC announces the appointment of managing partner Gerard Stranch as counsel for the negotiation class in the pending multi-district national prescription opioid litigation (MDL...
by Corporate Image | May 24, 2019 | Branstetter Stranch & Jennings
Ruling denies request by major pharmaceutical distributor to remove the case to federal level NASHVILLE, Tenn. — A ruling issued May 22, 2019, in the U.S. District Court for the Middle District of Tennessee has helped clear the way for a 19-county lawsuit against...
by Corporate Image | Apr 22, 2019 | Branstetter Stranch & Jennings
Action prompts filing of amendment to original discrimination complaint MEMPHIS — On the heels of a racial discrimination lawsuit filed by a former executive of Canadian National Railway Company (CN), the company and two subsidiaries have struck back with their own...
by Corporate Image | Mar 26, 2019 | Branstetter Stranch & Jennings
CHICAGO — For the fifth time in the past 10 years, Canadian National Railway Co. (CN) and its wholly owned subsidiary, Illinois Central Railroad Co. (IC), have been named defendants in a lawsuit alleging racial discrimination. Branstetter, Stranch & Jennings, PLLC...
